Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank75
3Y CAGR-5.4%
5Y CAGR-3.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-5.4%/yr
vs +33.0%/yr prior
5Y CAGR
-3.7%/yr
Consistent
Acceleration
-38.4pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $467.76M | +13.7% |
| 2024 | $411.29M | +17.1% |
| 2023 | $351.19M | -36.4% |
| 2022 | $551.80M | -13.8% |
| 2021 | $640.19M | +13.2% |
| 2020 | $565.78M | +60.7% |
| 2019 | $351.99M | +99.7% |
| 2018 | $176.27M | +0.4% |
| 2017 | $175.64M | +606.4% |
| 2016 | $24.86M | - |